SCHEMBL3825447

SCHEMBL3825447

NC(=O)c1nnc(-c2ccc(C(F)(F)F)cc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.57
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HPGD P15428 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTPN1 P18031 1/20 0.47
GSK3B P49841 2/20 0.47
CASP1 P29466 1/20 0.46
NOTUM Q6P988 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
KIF11 P52732 2/20 0.44
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8840233 0.86 PTPN1 (0.66) IKBKBKDM4EALDH1A1CYP1A2POLB
SCHEMBL30370203 0.82 NPC1 (0.51) KDM4EALDH1A1CYP1A2CYP2C19NPC1
SCHEMBL30968083 0.80 PKM (0.62) KDM4EALDH1A1POLBNPC1RAB9A
SCHEMBL18528795 0.79 NPC1 (0.69) IKBKBKDM4EALDH1A1CYP1A2POLB
SCHEMBL3823166 0.79 SMPD1 (0.65) IKBKBKDM4EALDH1A1POLBHSD17B10
SCHEMBL3093950 0.78 PTPN1 (0.69) IKBKBKDM4EALDH1A1HSD17B10NPC1
SCHEMBL327146 0.77 CA1 (0.64) KDM4EALDH1A1CYP1A2POLBCYP2C19
SCHEMBL5754354 0.76 KDM4E (0.71) IKBKBKDM4EALDH1A1CYP1A2POLB
SCHEMBL30968135 0.76 NPC1 (0.61) IKBKBKDM4EALDH1A1HSD17B10NPC1
SCHEMBL5203215 0.76 NPC1 (0.68) KDM4EALDH1A1CYP1A2POLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 IKBKB 1573/4885KDM4E 1955/4885ALDH1A1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.